Y-mAbs Therapeutics, Inc. Accumulated Other Comprehensive Income
Y-mAbs Therapeutics, Inc. had Accumulated Other Comprehensive Income of -$612.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-08-08
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$612.00K.
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.40M.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.26M.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$36.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-06-30 | -$612.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.40M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.26M 10-Q · filed 2025-08-08 |
| 2024-09-30 | -$36.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.05M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $848.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $449.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $1.85M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.04M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.02M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.33M 10-K · filed 2024-02-29 |
| 2022-09-30 | $4.70M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $3.10M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.68M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.37M 10-K · filed 2023-03-30 |
| 2021-09-30 | $225.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$13.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$91.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$526.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | -$28.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$16.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $75.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $50.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $131.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$3.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $63.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $7.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$48.00K 10-Q · filed 2018-11-13 |
| 2017-12-31 | -$169.00K 10-K · filed 2019-03-22 |